Indications
Praxbind is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required: for emergency surgery/urgent procedures; in life-threatening or uncontrolled bleeding.
Composition
- Active substance
- idarucizumab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Praxbind
- Active substance
- idarucizumab
- ATC code
- V03AB
- Group
- Various
- Therapeutic area
- Hemorrhage
- Marketing authorisation holder
- Boehringer Ingelheim International GmbH
- Status
- Authorised